SCHEMBL5712958

SCHEMBL5712958

Nc1sc2c(c1C(=O)c1ccc(I)cc1)CCN(C(=O)Nc1ccccc1)C2

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 6/20 0.49
MAPT P10636 2/20 0.49
KDM4E B2RXH2 1/20 0.49
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
ALDH1A1 P00352 2/20 0.47
LMNA P02545 1/20 0.47
GAA P10253 1/20 0.47
HPGD P15428 1/20 0.47
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
TP53 P04637 1/20 0.46
FAAH O00519 1/20 0.43
THRB P10828 1/20 0.42
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5712865 0.90 NPC1 (0.50) ADORA1MAPTKDM4EMEN1KMT2A
SCHEMBL5712947 0.90 MEN1 (0.62) ADORA1MAPTKDM4EMEN1KMT2A
SCHEMBL5342374 0.79 MAPT (0.63) ADORA1MAPTKDM4EMEN1KMT2A
SCHEMBL13738436 0.77 ADORA1 (0.58) ADORA1MAPTKDM4EMEN1KMT2A
SCHEMBL5712829 0.72 MEN1 (0.77) ADORA1MAPTKDM4EMEN1KMT2A
SCHEMBL135797 0.71 MAPT (0.59) ADORA1MAPTKDM4EMEN1KMT2A
SCHEMBL6992778 0.71 ADORA1 (0.67) ADORA1MAPTKDM4EMEN1KMT2A
SCHEMBL3768107 0.71 TDP1 (0.74) ADORA1MAPTKDM4EMEN1KMT2A
SCHEMBL5503933 0.71 MAPT (0.70) ADORA1MAPTKDM4EMEN1KMT2A
SCHEMBL13739025 0.71 ADORA1 (0.70) ADORA1MAPTKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1671973-A2 Allosteric adenosine receptor modulators King Pharmaceuticals Research and Development, Inc. (US) 2006-06-21 EP claimed
EP-1671973-A2 Allosteric adenosine receptor modulators King Pharmaceuticals Research and Development, Inc. (US) 2006-06-21 EP disclosed
EP-1025106-B1 ALLOSTERIC ADENOSINE RECEPTOR MODULATORS KING PHARMACEUTICALS RES & DEV (US) 2006-06-21 EP disclosed
US-6323214-B1 CARDIOVASCULAR DISORDERS, NERVOUS SYSTEM DISORDERS AND ANALGESICS MEDCO RESEARCH, INC 2001-11-27 US disclosed